Multicenter off-label experience in 4240 diagnostic ferumoxytol injections for MRI at nine sites in the United States and two sites in the United Kingdom showed no serious adverse events or adverse... Background Ferumoxytol is approved for use in the treatment of iron deficiency anemia, but it can serve as an alternative to gadolinium-based contrast agents. On the basis of postmarketing surveill...